Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00353483 · ClinicalTrials.gov registry record
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
A clinical trial of Breast Neoplasms, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT00353483: Recruiting study of Breast Neoplasms, sponsored by Washington University School of Medicine.
NCT00353483 is a study of Breast Neoplasms that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 300 participants, below the 566-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00353483, a study of Breast Neoplasms, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to compare genetic markers present on tumor cells before and after chemotherapy.
Conditions Studied
Interventions
- PROCEDURE Peripheral blood draw
- PROCEDURE Breast tissue collection
- PROCEDURE Bone marrow biopsy
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2005-09-14 |
| Est. Completion | 2026-08-31 |
What NCT00353483 shows while recruiting
NCT00353483 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 566-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Breast Neoplasms appearing as the primary indexed condition, and to 3 interventions - of which Peripheral blood draw is the first listed.
NCT00353483 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00353483 about?
NCT00353483 is a clinical study titled "Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells". The main purpose of this study is to compare genetic markers present on tumor cells before and after chemotherapy.
What is the current status of trial NCT00353483?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2005-09-14. Estimated completion is 2026-08-31.
What conditions does trial NCT00353483 study?
This clinical trial studies the following conditions: Breast Neoplasms.
What interventions are being tested in trial NCT00353483?
The interventions under investigation include: Peripheral blood draw (PROCEDURE), Breast tissue collection (PROCEDURE), Bone marrow biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00353483?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00353483 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00353483's enrollment target sits among peer trials
300 32nd of 97 higher than 65 of 97 other Breast Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
RECRUITING · Phase 2
-
Focused Ultrasound and Gemcitabine in Breast Cancer
RECRUITING · Phase 1
-
A Registry Study of Breast Microseed Treatment
RECRUITING
-
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RECRUITING · Phase 1
-
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RECRUITING · Phase 3
-
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
- NCT01266577 · 300 participants · NA
Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites in Human Brain and Muscle
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI